Use of High Flow Nasal Cannula During Sedation of Morbidly Obese Patients in the Endoscopy Suite



Status:Completed
Conditions:Obesity Weight Loss
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - Any
Updated:10/4/2018
Start Date:December 28, 2016
End Date:September 28, 2018

Use our guide to learn which trials are right for you!

Randomized. Controlled Trial of the Utilization of High Flow Nasal Cannula for Oxygenation of Sedated Morbidly Obese Patients in the Endoscopy Suite

This study evaluates the ability of high flow nasal cannula versus nasal cannula to oxygenate
morbidly obese patients undergoing moderate to deep sedation for gastrointestinal procedures.

The respiratory physiology of morbidly obese patients is altered due to restriction of the
chest wall motion which decreases pulmonary compliance. In addition, anatomical changes lead
to an increased incidence of airway obstruction in morbidly obese patients during periods of
sedation. Both a typical nasal cannula and high flow nasal cannula provide supplemental
oxygen to the patients to prevent desaturation and hypoxia. However, the higher flow rates of
high flow nasal cannulas are able to produce allows for washout of carbon dioxide from the
respiratory system aiding with ventilation and creates 3 to 5 cm H2O of positive end
expiration pressure which helps prevent collapse of the airway aiding with oxygenation.

Inclusion Criteria:

- Body Mass Index greater than or equal to 40

- Scheduled for a gastrointestinal endoscopy that requires MAC sedation

Exclusion Criteria:

- Body Mass Index less than 40

- Pregnant

- Require either invasive or non-invasive ventilation for respiratory failure

- Use home oxygen

- Ventilation is via a tracheostomy

- The procedure is emergent
We found this trial at
1
site
3550 Jerome Avenue
Bronx, New York 10467
(718) 920-4321
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
?
mi
from
Bronx, NY
Click here to add this to my saved trials